Abstract Mesenchymal stem cells (MSCs) have great therapeutic potential for the repair of nonhealing bone defects, because of their proliferative capacity, multilineage potential, trophic factor secretion and lack of immunogenicity. However, a major challenge to the translation of cell-based therapies into clinical practice is ensuring their survival and function upon implantation into the defect site. We hypothesize that forming MSCs into more physiologic three-dimensional spheroids, rather than employing dissociated cells from twodimensional monolayer culture, will enhance their survival when exposed to a harsh microenvironment but maintain their osteogenic potential. MSC spheroids were formed by using the hanging drop method with increasing cell numbers. Compared with larger spheroids, the smallest spheroids, which contained 15,000 cells, exhibited increased metabolic activity, reduced apoptosis and the most uniform distribution of proliferating cells. Spheroids were then entrapped in fibrin gels and cultured in serum-free medium and 1 % oxygen. Compared with identical numbers of dissociated MSCs in fibrin gels, spheroids exhibited significantly reduced apoptosis and secreted up to 100-fold more vascular endothelial growth factor. Moreover, fibrin gels containing spheroids and those containing an equivalent number of dissociated cells exhibited similar expression levels of early and late markers of osteogenic differentiation. Thus, MSC spheroids exhibit greater resistance to apoptosis and enhanced proangiogenic potential while maintaining similar osteogenic potential to dissociated MSCs entrapped in a clinically relevant biomaterial, supporting the use of MSC spheroids in cell-based approaches to bone repair.
Introduction
Bone has a remarkable capacity to heal and remodel following trauma or insult. However, native bone repair processes are insufficient for approximately 10 % of patients whose bone defects either extend beyond a critical size or are associated with impaired native healing secondary to age or disease. Clinically, these defects can manifest through nonunion fractures, deep-seated infections that require debridement, tumor resection or irradiation, inherited bone disorders, necrosis secondary to compromised blood supply and failed hip and knee replacements. In the United States alone, 1.6 million surgical procedures (at a cost of $5 billion) are performed annually that require some type of bone substitute (O'Keefe and Mao 2011). The gold standard for bone substitutes remains the autologous bone graft (Laurencin et al. 2006) , whereby healthy bone tissue is removed from a remote site, such as the iliac crest of the pelvic bone and used to fill the bone defect within the same patient. Although these autologous bone grafts minimize the risk of rejection and retain inherent osteogenic and osteoinductive properties, this approach is fraught with limitations including limited tissue availability and tissue morbidity at the collection site. All of these factors serve as the driving force for the development of engineered bone tissue that can be used in clinical practice.
Unlike materials-based strategies that are dependent upon the availability of responsive and functional host cells, cellbased therapies represent an exciting approach to promote tissue repair by delivering functional cells to the defect site. Mesenchymal stem cells (MSCs) are under widespread investigation because of their osteogenic and pro-angiogenic potential (Caplan and Dennis 2006; Decaris et al. 2012; Hoch et al. 2012) . These benefits, however, are often lost with successive passaging and expansion of these cells ex vivo, which relies on culturing them as a nonphysiologic monolayer (Siddappa et al. 2007) . Furthermore, although the surrounding milieu of a cell might be readily controlled in vitro, cells are often transplanted in vivo into a harsh ischemic environment lacking a microvascular network (Kneser et al. 2006) . This leads to sudden oxygen and nutrient deprivation, inducing massive cell death (Potier et al. 2007 ). Thus, we need to develop improved methods to enhance cell survival and maximize cell function for cell-based therapies in bone tissue engineering.
A number of strategies are under investigation to prime MSCs in an effective manner, prior to their implantation, in order to improve in vivo survival and function. Whereas the culture of MSCs in the presence of various exogenous growth factors enhances survival upon transplantation (Herrmann et al. 2010; Pasha et al. 2008 ), this approach is limited by an insufficient knowledge of the appropriate dosage and duration of factor exposure (Mehta et al. 2012) and by the high costs associated with prolonged use of recombinant proteins. Preconditioning in low oxygen has similar pro-survival effects and yet this approach can inhibit differentiation and stunt proliferation (Holzwarth et al. 2010) . Furthermore, these strategies seek to manipulate the behavior of cells grown in monolayer culture, a nonphysiologic condition. MSCs expanded in nonphysiologic monolayer culture rapidly undergo apoptosis following transplantation (Zhang et al. 2001) . However, the implantation of multiple cellular populations as interconnected sheets exhibits reduced apoptosis and prolonged survival compared with equivalent numbers of dissociated cells (Shimizu et al. 2002; Yang et al. 2005 ). This distinct improvement in survival is potentially attributable to the retention of critical cell-cell contacts that are established during culture but that are enzymatically severed with standard trypsinization methods. However, because of the limitations of diffusion, thick viable three-dimensional (3D) tissues such as bone cannot be created with this cell-sheet technology (Yang et al. 2005) .
In order to increase cell survival and the efficacy of stem cell therapy, our group and others have demonstrated that MSCs exhibit increased overall function when formed into spheroids, which are multicellular aggregates formed through promoting cell-cell interactions. Recent data reveal that MSC spheroids survive better in ischemic conditions compared with dissociated cells expanded in monolayer culture (Bhang et al. 2012a) . This is probably because spheroids avoid the need for cell detachment from the extracellular matrix (ECM), allowing them to preserve their native environment and provide essential signals for cell survival (Wang et al. 2009 ). Additionally, spheroid formation also greatly enhances the pro-angiogenic potential of MSCs, causing the up-regulation of a wide array of growth factors including vascular endothelial growth factor (VEGF), basic fibroblast growth factor, hepatocyte growth factor and angiogenin (Bhang et al. 2012a; Lee et al. 2012; Wang et al. 2009 ). However, the mentioned studies were performed with undifferentiated MSCs, whereas osteogenic induction of MSCs before transplantation is commonly employed to enhance the potential contribution of transplanted cells toward bone formation. The impact of spheroid formation by using osteogenically induced MSCs on cell survival, trophic factor secretion and osteogenesis is unknown.
We hypothesized that MSCs formed into 3D spheroids and suspended in fibrin hydrogels would exhibit increased survival and function when exposed to a harsh microenvironment compared with dissociated MSCs. To explore this hypothesis, we examined the osteogenic, pro-angiogenic and apoptotic resistance of MSC spheroids compared with cells expanded in monolayer culture. We examined the response of MSC spheroids to an experimentally controlled ischemic microenvironment when entrapped in fibrin gels as a model of their behavior upon implantation into tissue defects.
Materials and methods

Cell culture
Human bone-marrow-derived MSCs were purchased from Lonza (Walkersville, Md., USA) and were listed as being CD105-, CD166-, CD29-and CD44-positive and CD14-, CD34-and CD45-negative, as tested by flow cytometry. Cells were used without further characterization and during expansion, MSCs were seeded at approximately 4000 cells/cm 2 . Cells were cultured in αMEM (Invitrogen, Carlsbad, CA, USA) supplemented with 10 % fetal bovine serum (JR Scientific, Woodland, CA, USA) and 100 units/ml penicillin and 100 μg/ml streptomycin (Mediatech, Manassas, VA, USA) under standard culture conditions (37°C, 21 % O 2, 5 % CO 2 ) until use at passage 5.
Spheroid formation and characterization
Spheroidal aggregates of MSCs were formed by using the hanging drop technique (Del Duca et al. 2004 ) with 15,000, 30,000, or 60,000 cells per 25 μl droplet. Identical numbers of MSCs were plated as adherent monolayers in 12-well plates as controls. After spheroids had been allowed to aggregate for 48 h, spheroid diameter was quantified via bright field microscopy (n=12 per seeding density) and analyzed with ImageJ (NIH, Bethesda, MD, USA). The 25-μl droplets of medium containing spheroids were refreshed every 2 days by careful aspiration of 14 μl from and the addition of 20 μl to each droplet to account for evaporative loss.
Assessment of cellular viability, metabolism and proliferation
After allowing spheroids to aggregate for 48 h, MSC were lysed in passive lysis buffer (Promega, Madison, WI, USA) and apoptosis was quantitatively measured by analyzing 100 μl lysate per sample by using a Caspase-Glo 3/7 assay (Promega; Binder et al. 2014; Davis et al. 2011) . Luminescence was detected on a microplate reader and normalized to DNA content, which was determined from the same lysate by using the Quant-iT PicoGreen DNA Assay Kit (Invitrogen). In order to measure cellular metabolic activity, the medium was refreshed on adherent monolayers and the spheroids were collected and placed in 12-well plates with 1 ml αMEM. An aliquot of 100 μl Alamar Blue (Invitrogen) was added to both spheroid and monolayer wells and allowed to incubate with the cells for 3 h, after which fluorescence was detected on a microplate reader and normalized to total DNA content from the same sample.
The distribution of proliferating cells within intact spheroids and corresponding adherent monolayer cultures was determined by using a Click-iT EdU imaging kit (Invitrogen) according to the manufacturer's protocols. Spheroids were then fixed in 3 % glutaraldehyde (Fisher Scientific, Pittsburgh, PA, USA), counterstained with Hoechst and imaged by using a Nikon Eclipse TE2000U microscope (Melville, NY, USA) and a SpotRT digital camera (Diagnostic Instruments, Sterling Heights, MI, USA). Additional sections were stained with toluidine blue (Sigma Aldrich, St. Louis, MO, USA) to visualize cellular distribution.
Entrapment of spheroids into fibrin gels
Fibrin gels were prepared as we previously described (Davis et al. 2011; Murphy and Leach 2012) by combining 20 mg/ml fibrinogen (Calbiochem, Gibbstown, NJ, USA), 2.3 % (w/v) NaCl (Sigma Aldrich) 2.5 U/ml thrombin (Calbiochem), 20 mM CaCl 2 (Sigma Aldrich) and 250 KIU/ml aprotinin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), all in phosphate-buffered saline. Spheroids containing 15,000 cells/ sphere were allowed to form over 48 h and were suspended in fibrin gels at 2×10 6 cells/ml gel (e.g., four spheroids per 30 μl gel), cast into custom polydimethylsiloxane molds and allowed to gel for 1 h (Murphy and Leach 2012 ). An equal number of dissociated cells was suspended in gels as control groups. Gels were then transferred into individual wells of 24-well plates and the medium was refreshed every 3 days.
Spheroid response to impaired microenvironment
Fibrin gels containing spheroids or dissociated cells were allowed to equilibrate in αMEM under standard culture conditions for 24 h, after which their medium was exchanged for serum-free αMEM and they were moved to 1 % oxygen (serum-deprived/hypoxic conditions) by using oxygencontrolled HERAcell 150i incubators (Thermo Scientific, Pittsburgh, PA, USA). These conditions are sufficient to induce apoptosis in MSC (Binder et al. 2014) . Gels were collected in passive lysis buffer (Promega) at 0, 2 and 5 days following the change in culture environment, and cellular proliferation and apoptosis were quantified as described above. The medium was refreshed 24 h prior to collection and the concentration of VEGF in the medium was determined by using a human VEGF enzyme-linked immunosorbent assay kit according to the manufacturer's protocol (R&D Systems, Minneapolis, MN, USA).
Assessment of osteogenic potential
To determine whether osteogenic induction was required prior to spheroid formation, MSC were cultured as adherent monolayers for 10 days in either αMEM or osteogenic medium under full serum and normoxic conditions (OM; α-MEM supplemented with 10 mM β-glycerophosphate, 50 μg/ml ascorbate-2-phosphate, and 100 nM dexamethasone; all from Sigma). Cells were trypsinized and formed into 15,000-cell spheroids by using either α-MEM or OM and their osteogenic potential was assessed 7 days after spheroid formation by quantifying intracellular alkaline phosphatase (ALP) activity via a p-nitrophenyl phosphate assay and calcium deposition by using the o-cresolphthalein assay (Davis et al. 2013; Decaris et al. 2012) .
To assess the osteogenic potential of spheroids within fibrin gels, MSC in monolayer culture were osteogenically induced in OM for 10 days prior to spheroid formation (15,000 cells/ spheroid). Spheroids were formed over 48 h and then suspended in fibrin gels at 2×10 6 cells/m gel as described above and an equal number of dissociated cells were suspended in gels as control groups. Gels were then cultured in OM for up to 21 days. The osteogenic potential of the entrapped MSC was determined by quantifying ALP activity and calcium deposition at 0, 7, 14 and 21 days following gel fabrication (Davis et al. 2013 ).
Statistical analysis
Data are presented as means ± standard deviation. Statistical analysis was performed by using two-way analysis of variance with the Bonferroni correction for multiple comparisons in Prism 6 software (GraphPad); P-values of less than 0.05 were considered statistically significant.
Results
Spheroid formation and characterization
The hanging drop technique enabled MSCs to coalesce into a single spheroid per droplet and spheroids were visible to the naked eye within 48 h. Spheroid diameter increased linearly with increasing cell number, ranging from 394±53 μm for the 15,000-cell spheroid to 1,049±196 μm for the 60,000-cell spheroid (Fig. 1a) .
Metabolic activity, viability and proliferation of MSC spheroids is dependent on size
The smallest spheroids formed of 15,000 cells exhibited increased metabolic activity as measured by Alamar Blue (Fig. 1b) and reduced caspase 3/7 activity, indicative of less apoptosis, compared with the larger 30,000-cell and 60,000-cell spheroids (P<0.001). The 30,000-cell and 60,000-cell spheroids exhibited higher caspase activity than their adherent counterparts (P<0.05, P<0.01, respectively); however, caspase activity within 15,000-cell spheroids was comparable with that of its adherent counterpart (Fig. 1c) . The 15,000-cell spheroids also had the most uniform distribution of proliferating cells, as indicated by sections stained for EdU and Hoechst (Fig. 1d) . Spheroids formed from 30,000 and Fig. 1 Spheroid diameter, metabolic activity, viability and proliferation of mesenchymal stem cells (MSCs) can be controlled by cell number. a Spheroid diameter increases linearly with increasing cell number (n=12). b Smaller 15,000-cell spheroids exhibit increased metabolic activity, as measured by Alamar Blue, than the larger 30,000-cell and 60,000-cell spheroids (*P<0.05 vs. 30,000-cell spheroid, ****P<0.0001 vs. 60,000-cell spheroid; n=6; RU relative units). c Smaller 15,000-cell spheroids exhibit reduced apoptosis, as measured by caspase 3/7 activity, than the larger 30,000-cell and 60,000-cell spheroids (***P<0.001 vs. 30,000-cell and 60,000-cell spheroids; n=6; RLU relative light units). d EdU (green) and Hoechst (blue) staining revealed that the cells in the 15,000-cell spheroid (left) are more proliferative than those in the larger 30,000-cell (middle) and 60,000-cell (right) spheroids. Bar 500 μm. e Toluidine blue staining indicates that the 15,000-cell spheroids are more compact than the larger 30,000-cell and 60,000-cell spheroids. Bar 500 μm 60,000 cells exhibited large voids and uneven morphology compared with the more compact 15,000-cell spheroids (Fig. 1e) . The 15,000-cell spheroid exhibited the greatest viability amongst the three sizes evaluated; thus, 15,000-cell spheroids were used for all subsequent studies.
MSC spheroids entrapped in fibrin gels resist apoptosis and secrete more VEGF When cultured in serum-free medium and 1 % oxygen, entrapped spheroids exhibited significantly reduced caspase activity, indicative of less apoptosis, compared with dissociated MSCs (Fig. 2a) . In both groups, normalized caspase activity decreased over 5 days, possibly as a result of the loss of more vulnerable cells upon changing culture conditions and the persistence of more robust cells in culture. Additionally, MSC spheroids secreted up to 100 times the amount of VEGF compared with an equal number of dissociated MSCs (Fig. 2b) . Proliferation, as measured by DNA content, did not differ between the entrapped spheroids and dissociated cells and these trends were observed in all serum-oxygen tension combinations ( Supplementary Fig. 1 ). Sections of fibrin gels stained with hematoxylin and eosin indicated that the cells slowly migrated out of the spheroids into the surrounding gel and after 5 days in culture, both groups appeared morphologically similar (Fig. 2e, h ).
Osteogenic potential of MSC spheroids is dependent upon timing of induction
We examined the contribution of the timing of exposure to OM on spheroid formation and osteogenic potential. When cells were cultured in αMEM for 10 days prior to OM exposure, MSC spheroids exhibited significantly lower ALP activity, an early marker of osteogenesis, compared with adherent monolayers. However, if both spheroids and adherent monolayers were exposed to OM throughout the experiment, ALP activity was not statistically different between the two groups (Fig. 3a) . Calcium content, a late-stage marker of osteogenesis, significantly increased in both MSC spheroids and adherent monolayers as the duration of culture in OM was increased (Fig. 3b) . For all media combinations, the total normalized calcium content was higher in spheroids compared with adherent monolayers. Absolute DNA content was greater for adherent monolayers than for MSC spheroids, with no statistical differences being found between media groups ( Supplementary Fig. 2 ). 
Spheroid osteogenic potential in fibrin gels is comparable with that of dissociated MSCs
In light of the data presented above, we osteogenically induced MSCs for 10 days prior to the formation of 15,000-cell spheroids in order to examine the osteogenic potential of MSCs entrapped in fibrin gels over time. We did not detect any differences in ALP activity (Fig. 4a ) or calcium secretion (Fig. 4b) for spheroids entrapped in fibrin gels over the 21-day period compared with an equivalent number of dissociated cells. Cells persisted in the gels throughout the 21-day period and by 7 days, the cells had migrated out of the spheroids and were morphologically similar to the dissociated cells in gels (Fig. 4c) .
Discussion
In this study, we examined the viability and pro-angiogenic and osteogenic potential of MSC spheroids compared with those of MSCs maintained as traditional adherent monolayers and/or dissociated cells. We report that MSC spheroids formed of 15,000 cells exhibit greater resistance to apoptosis and increased secretion of VEGF, a potent trophic factor that enhances collateral vessel formation, under normoxic, hypoxic, full serum and serum-free conditions. Furthermore, spheroids are as responsive to osteogenic induction as their monolayer or dissociated cell counterparts and exhibit similar osteogenic potential when cultured in fibrin gels, which is a promising vehicle for cell delivery. These data provide strong evidence that the formation of MSCs into spheroids has the potential to facilitate the clinical translation of MSC-based therapies for the repair of nonhealing bone defects. Spheroids can be formed by using numerous techniques including agarose-coated wells (Friedrich et al. 2009; Laschke et al. 2013) , siliconized spinner flasks (Frith et al. 2010 ; Kunz-S ch u gh a r t e t a l . 1 99 8 ; Mu e l l e r-K l i es e r 1 99 7) , methylcellulose-containing medium (Correa de Sampaio et al. 2012; Wang et al. 2009 ) and specialized plates (Fey and Wrzesinski 2012; Lai and Kisaalita 2012) . We employed the hanging drop technique (Bartosh et al. 2010 ) because of its simplicity, reliability and cost-effectiveness. Various sizes of spheroids were investigated, ranging from 50 μm (Wenger et al. 2004 ) to 1,500 μm (Bartosh et al. 2010) . The size of these 3D multicellular aggregates must be considered carefully because of limitations in the diffusive length of nutrient transport (Curcio et al. 2007 ), a feature that renders cells in the core of spheroids with radii greater than 200 μm vulnerable to hypoxia and cell death. The presence of a hypoxic core within the spheroid might preprogram the cells to promote survival (Korff and Augustin 1998) and enhance trophic factor secretion (Shweiki et al. 1995) . Thus, additional advantages might be conferred when utilizing a spheroid whose radius is near the nutrient transport limitation. However, the link between a hypoxic core and cell activity has not been firmly demonstrated. We chose to examine the range of 15,000-60,000 cells per spheroid, as others have observed that MSC spheroids within this range exhibit radii in the order of 200 μm (Bartosh et al. 2010; Bhang et al. 2012b ). In our study, spheroids containing approximately 15,000 cells had a mean radius of approximately 200 μm and were subsequently the most viable, as measured by caspase 3/7 activity, metabolic activity and proliferation, compared with spheroids of larger sizes. We did not examine smaller spheroid sizes, which would have required fewer cells, in order to maintain a radius near the limitation of diffusive nutrient transport. Furthermore, cell-based therapies require Fig. 3 Osteogenic potential of MSC spheroids and adherent monolayers is influenced by timing of osteogenic induction. Osteogenic potential was assessed 7 days after spheroid formation. a When cells were cultured in αMEM prior to spheroid formation in osteogenic medium (OM, −), alkaline phosphatase (ALP) activity was significantly lower in spheroidal culture compared with adherent monolayers. However, ALP activity was not statistically different between the two groups if both spheroid and adherent monolayers received OM (+) throughout the experiment (****P<0.0001 vs. spheroids, n=4). b Calcium content significantly increased in both MSC spheroids and adherent monolayers as the duration of culture in OM increased (**P<0.01 vs. spheroids, ****P<0.0001 vs. spheroids, n=4) a substantial number of cells to be delivered in order to drive tissue formation and larger spheroids facilitate the transplantation of fewer aggregates.
These studies confirm that spheroidal conformation drastically increases the production of VEGF, a potent mediator of angiogenesis. Bone formation is dependent upon angiogenesis and many studies have indicated that accelerated angiogenesis enhances bone formation (He et al. 2010 (He et al. , 2012 Kaigler et al. 2006; Leu et al. 2009 ). However, the pro-angiogenic potential of MSCs is inversely related to their degree of osteogenic differentiation (Hoch et al. 2012) . Spheroidal formation of MSCs might address this shortcoming, as MSC spheroids entrapped in a fibrin gel secrete 100-fold more VEGF than an equal number of dissociated cells while exhibiting similar osteogenic potential. Although these changes have been observed under serum-free and hypoxic conditions lacking osteogenic cues, the magnitude of VEGF increase provides support for the use of MSC spheroids to promote mineral deposition, as they can simultaneously establish a vascular network.
In contrast to MSCs expanded in a monolayer that must be trypsinized from tissue culture plastic, spheroidal culture preserves cell-cell contacts and native ECM thought to provide the survival advantage that we and others have observed (Wang et al. 2009 ). This survival advantage, however, cannot come at the expense of osteogenic potential. Baraniak and McDevitt (2012) demonstrated that MSC spheroids retain their trilineage potential. Our study builds upon these findings by demonstrating that, upon incorporation into a clinically relevant biomaterial, MSC spheroids are as osteogenic as dissociated cells. However, our results demonstrate that, if MSCs are not osteogenically induced prior to spheroid formation, the spheroids appear to lack osteogenic potential as measured by ALP activity. This phenomenon possibly stems from the fact that MSCs grown as adherent monolayers receive both soluble and mechanical osteogenic cues, whereas spheroids in hanging drops rely solely on soluble cues. Tissue culture plastic possesses a Young's Modulus of approximately 3 GPa and, as has been well demonstrated, MSCs grown on stiff substrates exhibit increased osteogenic potential (Engler et al. 2006; Titushkin and Cho 2007; Winer et al. 2009 ). Thus, the incorporation of the cells into a relevant biomaterial allows a more equal comparison in terms of osteogenic potential. Similar to cells grown as monolayers, MSC spheroids respond to soluble osteogenic cues with increased ALP activity and mineral deposition indicative of osteogenic differentiation. The cell density within the fibrin gel might also contribute to our detected differences. Even at a consistent seeding density (2×10 6 cells/ ml), differences probably occur in cell-cell contact and communication between MSC spheroids and dissociated cells. The effect of seeding density on spheroid function in fibrin hydrogels merits further investigation. This study provides strong evidence that spheroid formation does not inhibit the responsiveness of MSCs in spheroidal form to osteogenic cues, thereby harnessing the survival advantage of spheroids without sacrificing their ability directly to participate in bone formation.
Whereas others have transplanted spheroids in vivo without a biomaterial carrier (Bhang et al. 2011 (Bhang et al. , 2012b , primarily for promoting neovascularization of ischemic tissue, the delivery of cells within a biomaterial can promote cell persistence at the defect site and provide cues to guide cellular differentiation. Fibrin gels are particularly promising as a cell delivery vehicle, as endogenously, fibrin serves as a scaffold for tissue repair and regeneration and a provisional matrix for the invasion of regenerative cells. Furthermore, fibrin gels can be delivered in a minimally invasive approach or molded to specific shapes and are "tunable" in order to achieve a particular gelation rate, compressive stiffness and degradation rate (Barsotti et al. 2011; Davis et al. 2011; Janmey et al. 2009; Shaikh et al. 2008 ). In agreement with similar studies, we observed that MSCs entrapped in fibrin gels are capable of proliferation, osteogenic differentiation and the secretion of pro-angiogenic factors (Davis et al. 2011) . When cultured in fibrin gels, entrapped MSCs migrate out of the spheroid and into the surrounding biomaterial. These findings are in agreement with others that have shown MSCs migrate out of the spheroid when plated on adherent culture surfaces (Bartosh et al. 2010) . Thus, the maintenance of MSCs as spheroids is not required for continued performance, indicating that spheroidal conformation can be used as a tool to precondition the entrapped MSCs. Additionally, the material properties of the fibrin gel should be considered when choosing a delivery vehicle for MSC spheroids, as cell migration through the gel might play a key role in their enhanced survival and osteogenic potential.
In conclusion, our results demonstrate that MSCs formed into 3D spheroids, compared with those derived from traditional 2D monolayer culture, maintain their osteogenic potential and exhibit improved survival when exposed to a harsh microenvironment. MSCs formed as spheroids secrete significantly more VEGF and exhibit greater resistance to apoptosis compared with dissociated MSCs, suggesting that they will promote angiogenesis and be more apt to survive than dissociated cells upon transplantation. Additionally, the formation of MSCs into spheroids does not inhibit their responsiveness to osteogenic induction. Collectively, our findings demonstrate that the spheroidal culture of MSCs has the potential to facilitate the clinical translation of MSC-based therapies for the repair of slow-and non-healing bone defects.
